Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Krop IE, Kim SB, González-Martín A. et al TH3RESA study collaborators.
Trastuzumab emtansine versus treatment of physician’s choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial.

Lancet Oncol 2014;
15 (07) 689-699

Bibliographische Angaben herunterladen

Aufrufen in: